30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 16 Label Accuracy in Psychedelic Products

This podcast episode explores the critical importance of label accuracy in psilocybin products, drawing parallels to early challenges in the cannabis industry. The discussion covers key topics including:- The use of advanced testing methods like LCMS (liquid chromatography mass spectrometry) to accurately measure psilocybin and psilocin levels- Current challenges in the unregulated market, described as a "Wild West" environment with varying product quality and potency- The FDA's emerging role in regulation through PDUFA guidelines- Special considerations for different product forms, including dried mushrooms, extracts, and microdosing productsThe episode emphasizes how accurate labeling is fundamental to consumer safety, market trust, and the responsible development of the psychedelic industry.